McKesson Buys Precision Medicine for 2.25 Billion
McKesson agreed to purchase Precision Medicine Group for approximately 2.25 billion dollars. The acquisition aims to boost the drug distributor clinical research and oncology services.
Xurve View
Insights:
Xurve View
MCKESSON CORP agreed on Tuesday morning to acquire Precision Medicine Group for $2.25 billion in cash. The transaction expands the distributor's oncology and specialty care footprint. The purchase represents just over 2% of McKesson's total market capitalization.
